Ratings by China Renaissance (Bing Zhao)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/7/2021 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2021 | BeiGene, Ltd. | BGNE | New Coverage | Buy (N/A) |
289.22 (129.09) |
-55.37% | Details | |
| 2/12/2020 | I-Mab | IMAB | New Coverage | Buy (N/A) |
11.00 (1.82) |
-83.45% | Details | |
| 9/4/2019 | Zai Lab | ZLAB | New Coverage | Buy (N/A) |
32.61 (14.06) |
-56.88% | Details |
